The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
Public ClinicalTrials.gov record NCT01137812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Versus Sitagliptin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sulphonylurea Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin in patients with type 2 diabetes mellitus who are receiving treatment with metformin and sulphonylurea and have inadequate glycemic (blood sugar) control.
Study identification
- NCT ID
- NCT01137812
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 756 participants
Conditions and interventions
Conditions
Interventions
- Sitagliptin 100 mg Drug
- Canagliflozin 300 mg Drug
- Metformin Drug
- Sulphonylurea Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2010 (Type not available)
- Primary completion
- Mar 2012 (Actual)
- Completion
- Mar 2012 (Actual)
- Last update posted
- Jan 15, 2015
2010 – 2012
United States locations
- U.S. sites
- 85
- U.S. states
- 26
- U.S. cities
- 85
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | — | — |
| Not listed | Goodyear | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Escondido | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Greenbrae | California | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | Laguna Hills | California | — | — |
| Not listed | Lancaster | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Norwalk | California | — | — |
| Not listed | Pismo Beach | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Watsonville | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Northglenn | Colorado | — | — |
| Not listed | Milford | Connecticut | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Cape Coral | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Delray Beach | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Lewiston | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | O'Fallon | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | Bowling Green | Kentucky | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Madisonville | Kentucky | — | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Mandeville | Louisiana | — | — |
| Not listed | Metairie | Louisiana | — | — |
| Not listed | Sunset | Louisiana | — | — |
| Not listed | Brockton | Massachusetts | — | — |
| Not listed | Saint Clair Shores | Michigan | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Dakota Dunes | Nebraska | — | — |
| Not listed | Toms River | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | West Seneca | New York | — | — |
| Not listed | Calabash | North Carolina | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Moerhead City | North Carolina | — | — |
| Not listed | Morganton | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Gallipolis | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Mason | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Zanesville | Ohio | — | — |
| Not listed | Beaver | Pennsylvania | — | — |
| Not listed | Bensalem | Pennsylvania | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Perryopolis | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Pottstown | Pennsylvania | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Johnson City | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Killeen | Texas | — | — |
| Not listed | Richardson | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Schertz | Texas | — | — |
| Not listed | Sugar Land | Texas | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Danville | Virginia | — | — |
| Not listed | Falls Church | Virginia | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Henrico | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Selah | Washington | — | — |
| Not listed | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01137812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 15, 2015 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01137812 live on ClinicalTrials.gov.